But, its important to take it slowly
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Am J Physiol Regul Integr Comp Physiol (2004) 287:R56874
Track any side effects, appetite changes, or shifts in energy levels
Quick Comparison Mazdutide is developed by Innovent Biologics, which holds the rights in China, while Eli Lilly retains development rights for the rest of the world